+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

NGS Kits Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 195 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925145
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The next generation sequencing kits market is transforming how organizations manage genomics, offering new avenues for research, diagnostics, and biotechnological innovation. For leadership teams, keeping pace with technology and evolving industry frameworks is crucial for operational resilience and ongoing competitiveness.

Market Snapshot: Next Generation Sequencing Kits Market

The global next generation sequencing kits market is charting stable expansion, posting a compound annual growth rate of 6.28%. In 2024, market value stands at USD 2.44 billion, with projections of USD 2.60 billion for 2025 and a notable surge to USD 3.98 billion by 2032. Demand is propelled by advances in high-throughput sequencing technologies, faster clinical adoption, and continuous product enhancement. Sector players are leveraging improved operational efficiency and strategic partnerships to secure competitive advantage. Adapting product portfolios to meet regulatory requirements and trends toward personalized medicine ensures relevance and long-term market performance.

Scope & Segmentation: Next Generation Sequencing Kits Market

This analysis delivers targeted insights to support operational and growth objectives across diagnostics, research, and biotech sectors. Coverage includes segmentation by product type, application, end user, technology, and region:

  • Product Type: Encompasses library preparation kits (amplicon, RNA-Seq, whole genome), sequencing kits for varied platforms (Nanopore, By Synthesis), and template preparation kits (bridge PCR, emulsion PCR), tailored to meet specialized research and clinical requirements.
  • Application: Includes exome sequencing for clinical and investigation purposes, targeted sequencing using hybridization or PCR techniques, transcriptome analysis at single-cell and population levels, and comprehensive whole genome sequencing, addressing diverse scientific and diagnostic aims.
  • End User: Serves the needs of academic research organizations, clinical diagnostics laboratories, and pharmaceutical biotechnology enterprises that rely on sequencing kits for knowledge progression and new solution development.
  • Sequencing Technology: Integrates Nanopore sequencing, Sequencing By Ligation, and Sequencing By Synthesis, each supporting unique workflow preferences concerning accuracy, throughput, and cost-effectiveness in research and diagnostics.
  • Region: Analyzes the Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (United Kingdom, Germany, France, key additional markets), and Asia-Pacific (China, India, Japan, Australia, emerging regions), capturing market adoption rates and regulatory frameworks.

Key industry contributors—Illumina, Thermo Fisher Scientific, Roche Holding, Danaher, MGI Tech, Agilent Technologies, PerkinElmer, Takara Bio, Oxford Nanopore Technologies, and Twist Bioscience—continue to advance product development and increase market reach through global distribution networks.

Key Takeaways for Senior Decision-Makers

  • Ongoing innovation in reagent chemistry and workflow automation raises kit reliability across both research and healthcare environments, helping minimize process errors and enhancing result consistency.
  • Expansion of kit functionality now accommodates advanced uses, such as rare disease identification, cancer profiling, and scalable microbiome research—broadening their impact in diagnostics and discovery.
  • Collaboration among developers, suppliers, and users leads to highly configurable sequencing solutions, better suited to shifting operational goals in varied organizational settings.
  • Region-specific regulatory environments prompt organizations to focus on robust compliance and validation models, enabling faster market response and streamlined entry strategies.
  • Attention to factors like reproducibility, transparent technical documentation, and agile customer support are driving higher trust and improved quality benchmarks industry-wide.
  • Supply chain improvements in Asia-Pacific and select developing countries are reducing distribution delays, strengthening logistics infrastructure, and lowering vulnerability to materials shortages.

Tariff Impact on the Next Generation Sequencing Kits Market

New U.S. tariffs targeting sequencing reagents and components have complicated supply chain management for the sector. To navigate shifting cost structures, manufacturers are reorganizing supplier relationships and developing stronger local partnerships. These efforts are aimed at enhancing cost control and ensuring business continuity. Such measures reinforce the importance of resilient operations and highlight the value of proactive distribution strategies under changing trade policies.

Methodology & Data Sources

The insights in this report are informed by a blend of secondary research—industry publications, academic resources, patent surveys, regulatory guidelines—and primary conversations with R&D executives, laboratory managers, and supply chain leaders. Peer review and data triangulation safeguard the accuracy and business relevance of the analysis.

Why This Report Matters for Market Leaders

  • Enables strategic product development by identifying high-potential market segments and aligning resources to current regulations and customer expectations.
  • Delivers actionable guidance on operational risk management, including mitigation strategies for supply chain volatility and trade-related challenges.
  • Supports growth through informed decision-making on digital workflow adoption, partnership optimization, and the strengthening of quality systems.

Conclusion

Consistent success in the next generation sequencing kits market hinges on adaptable product planning, integrated technology, and robust supply strategies. This resource equips leaders to anticipate industry evolution and act with confidence amid rapid change.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of automated microfluidics and robotics in NGS kits for high-throughput clinical diagnostics
5.2. Adoption of CRISPR-based target enrichment NGS kits to enhance rare variant detection sensitivity
5.3. Expansion of single-cell sequencing NGS kits enabling simultaneous multiomic profiling at single-cell level
5.4. Emergence of portable nanopore-based NGS kits facilitating real-time genomic surveillance in remote settings
5.5. Development of cost-effective multiplexed NGS kits optimized for large-scale population genomic screening
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. NGS Kits Market, by Product Type
8.1. Library Preparation Kits
8.1.1. Amplicon Library Kits
8.1.2. RNA-Seq Library Kits
8.1.3. Whole Genome Library Kits
8.2. Sequencing Kits
8.2.1. Nanopore Sequencing Kits
8.2.1.1. Biological Nanopore Kits
8.2.1.2. Solid-State Nanopore Kits
8.2.2. Sequencing By Synthesis Kits
8.3. Template Preparation Kits
8.3.1. Bridge PCR Kits
8.3.2. Emulsion PCR Kits
9. NGS Kits Market, by Application
9.1. Exome Sequencing
9.1.1. Clinical Exome Sequencing
9.1.2. Research Exome Sequencing
9.2. Targeted Sequencing
9.2.1. Hybridization Based Targeted Sequencing
9.2.2. PCR Based Targeted Sequencing
9.3. Transcriptome Sequencing
9.3.1. Bulk RNA Sequencing
9.3.2. Single Cell RNA Sequencing
9.4. Whole Genome Sequencing
10. NGS Kits Market, by End User
10.1. Academic Research Institute
10.1.1. Government Research Centers
10.1.2. University Laboratories
10.2. Clinical Diagnostic Laboratories
10.2.1. Hospital Diagnostic Laboratories
10.2.2. Independent Diagnostic Laboratories
10.3. Pharmaceutical Biotechnology Companies
10.3.1. Biotechnology Startups
10.3.2. Global Pharmaceutical Companies
11. NGS Kits Market, by Sequencing Technology
11.1. Nanopore Sequencing
11.1.1. Biological Nanopore
11.1.2. Solid-State Nanopore
11.2. Sequencing By Ligation
11.3. Sequencing By Synthesis
12. NGS Kits Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. NGS Kits Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. NGS Kits Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Illumina, Inc.
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Roche Holding AG
15.3.4. Danaher Corporation
15.3.5. MGI Tech Co., Ltd.
15.3.6. Agilent Technologies, Inc.
15.3.7. PerkinElmer, Inc.
15.3.8. Takara Bio Inc.
15.3.9. Oxford Nanopore Technologies plc
15.3.10. Twist Bioscience Corporation

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this NGS Kits market report include:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Roche Holding AG
  • Danaher Corporation
  • MGI Tech Co., Ltd.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Takara Bio Inc.
  • Oxford Nanopore Technologies plc
  • Twist Bioscience Corporation

Table Information